InVivo Therapeutics Holdings Corp.
NVIV
|
$0.3207
-25.16%
1.9M
|
Health Technology
(0.0% 1d) (0.0% 1m) (-59.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-98.2% volume)
Earnings Calendar:
Market Cap: $ 995,917
http://www.invivotherapeutics.com
Sec Filling | Patents | 6 employees
(US) Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert Langer in January 2005 and is headquartered in Cambridge, MA.
spinal cord msa treatment
add to watch list Paper trade email alert is off
Press-releases
Delisting of Securities of Latch, Inc.; Eloxx Pharmaceuticals, Inc.; Collective Audience, Inc. (f.k.a., ABRIC SPAC I); SeqLL Inc.; Nemaura Medical Inc.; LumiraDx Limited; Cemtrex Inc.; COMSovereign Holding Corp.; Global System Dynamics; Arrival; Nubia Brand International Corp.; The Alkaline Water Company Inc.; DMK Pharmaceuticals Corporation; MedAvail Holdings, Inc.; InVivo Therapeutics Holdings Corp.; and ADDvantage Technologies Group, Inc. from The Nasdaq Stock Market
Published: 2024-03-20 (Crawled : 20:00) - globenewswire.com
COMS | $0.2001 37.35% 1.5K
|
Manufacturing
|
| O: -2.27%
H: 27.46%
C: 15.87%
WTER | $0.0015 14185.71% 1.3K
|
Consumer Non-Durables
|
| O: 0.0%
H: 614.29%
C: 0.0%
NDAQ | $61.51 0.69% 0.68% 2.8M
|
Finance
|
| O: 0.46%
H: 3.09%
C: 1.11%
CETX | $2.03 -18.47% -22.66% 140K
|
Electronic Technology
|
| O: 0.22%
H: 1.85%
C: -2.22%
water company international spac pharmaceuticals global system medical therapeutics market
InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury
Published: 2023-03-09 (Crawled : 17:00) - biospace.com/
NVIV | $0.3207 -25.16% 1.9M
|
Health Technology
|
| O: -43.66%
H: 7.5%
C: -5.0%
inspire topline therapeutics study
InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules
Published: 2022-10-07 (Crawled : 13:00) - biospace.com/
NVIV | $0.3207 -25.16% 1.9M
|
Health Technology
|
| O: -24.19%
H: 0.0%
C: -33.06%
nasdaq therapeutics
Peptilogics Presents Data Demonstrating Antimicrobial Activity Against Difficult to Treat Bacterial Pathogens of Engineered Peptide PLG0206 Peptilogics, a clinical stage biotech company engineering pep...
Published: 2022-10-07 (Crawled : 13:00) - biospace.com/
AMLX A | $1.88 -3.59% -3.72% 1.4M
|
|
| O: -0.34%
H: 3.55%
C: -0.76%
FWBI | $3.04 -2.56% -2.63% 37K
|
Manufacturing
|
| O: 4.94%
H: 20.59%
C: -10.59%
BBLG | $1.59 -0.63% -0.63% 60K
|
n/a
|
| O: -33.33%
H: 11.57%
C: -3.3%
HUM 4 | $315.98 -3.66% -1.19% 3.3M
|
Health Services
|
| O: -0.26%
H: 1.28%
C: 1.1%
MDWD | $17.54 6.89% 6.44% 48K
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: -6.25%
NVIV | $0.3207 -25.16% 1.9M
|
Health Technology
|
| O: -24.19%
H: 0.0%
C: -33.06%
BMRN | $91.25 -0.88% -0.89% 1.6M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: -3.3%
ATXI | $0.0949 -29.18% -41.2% 12M
|
Health Technology
|
| O: -60.73%
H: 0.0%
C: 0.0%
plg0206 biotech pathogens
InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-09 (Crawled : 20:00) - biospace.com/
NVIV | $0.3207 -25.16% 1.9M
|
Health Technology
|
| O: 5.26%
H: 12.07%
C: 2.07%
global conference therapeutics
Movers & Shakers: Astria, Apertura, CytoDyn, IN8bio & More Make Big Moves
Published: 2022-07-15 (Crawled : 14:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 4.64%
H: 0.0%
C: 0.0%
CYDY | $0.15 0.06% 420K
|
Manufacturing
|
| O: 0.25%
H: 14.69%
C: 9.7%
ABSI | $4.51 -4.25% -4.43% 850K
|
|
| O: 2.46%
H: 2.25%
C: 1.5%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.76%
H: 0.0%
C: 0.0%
KMDA | $5.16 1.18% 1.16% 11K
|
Health Technology
|
| O: -3.66%
H: 8.72%
C: 7.38%
NVIV | $0.3207 -25.16% 1.9M
|
Health Technology
|
| O: -1.2%
H: 0.46%
C: -2.3%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: 1.42%
H: 0.92%
C: 0.76%
BioSpace Movers & Shakers: Astria, Apertura, CytoDyn, IN8bio & More Make Big Moves
Published: 2022-07-15 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 4.64%
H: 0.0%
C: 0.0%
CYDY | $0.15 0.06% 420K
|
Manufacturing
|
| O: 0.25%
H: 14.69%
C: 9.7%
ABSI | $4.51 -4.25% -4.43% 850K
|
|
| O: 2.46%
H: 2.25%
C: 1.5%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.76%
H: 0.0%
C: 0.0%
KMDA | $5.16 1.18% 1.16% 11K
|
Health Technology
|
| O: -3.66%
H: 8.72%
C: 7.38%
NVIV | $0.3207 -25.16% 1.9M
|
Health Technology
|
| O: -1.2%
H: 0.46%
C: -2.3%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: 1.42%
H: 0.92%
C: 0.76%
BioSpace Movers & Shakers: Astria, Apertura, CytoDyn, IN8bio & More Make Big ...
Published: 2022-07-15 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 4.64%
H: 0.0%
C: 0.0%
CYDY | $0.15 0.06% 420K
|
Manufacturing
|
| O: 0.25%
H: 14.69%
C: 9.7%
ABSI | $4.51 -4.25% -4.43% 850K
|
|
| O: 2.46%
H: 2.25%
C: 1.5%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.76%
H: 0.0%
C: 0.0%
KMDA | $5.16 1.18% 1.16% 11K
|
Health Technology
|
| O: -3.66%
H: 8.72%
C: 7.38%
NVIV | $0.3207 -25.16% 1.9M
|
Health Technology
|
| O: -1.2%
H: 0.46%
C: -2.3%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: 1.42%
H: 0.92%
C: 0.76%
Movers & Shakers: Apertura, CytoDyn, IN8bio & More Make Big Moves
Published: 2022-07-15 (Crawled : 13:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 4.64%
H: 0.0%
C: 0.0%
CYDY | $0.15 0.06% 420K
|
Manufacturing
|
| O: 0.25%
H: 14.69%
C: 9.7%
ABSI | $4.51 -4.25% -4.43% 850K
|
|
| O: 2.46%
H: 2.25%
C: 1.5%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.76%
H: 0.0%
C: 0.0%
KMDA | $5.16 1.18% 1.16% 11K
|
Health Technology
|
| O: -3.66%
H: 8.72%
C: 7.38%
NVIV | $0.3207 -25.16% 1.9M
|
Health Technology
|
| O: -1.2%
H: 0.46%
C: -2.3%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: 1.42%
H: 0.92%
C: 0.76%
InVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General Counsel
Published: 2022-07-13 (Crawled : 13:00) - biospace.com/
NVIV | $0.3207 -25.16% 1.9M
|
Health Technology
|
| O: 0.4%
H: 9.88%
C: 7.64%
therapeutics
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Last 48 Hours Insiders Buying
RKT P 347 | $12.55 -0.63% 0.48% 1.7M
|
Finance
|
22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K
|
Finance
|
22:00
TGEN P 10000 | $0.685 39.71% 6.6K
|
Utilities
|
20:01
MNSB P 310 | $15.88 -2.93% -3.02% 46K
|
Finance
|
15:30
RMCF | $3.54 0.28% 7.1K
|
Consumer Non-Durables
|
20:10